Product NDC: | 0093-4145 |
Proprietary Name: | Levalbuterol |
Non Proprietary Name: | Levalbuterol |
Active Ingredient(s): | .31 mg/3mL & nbsp; Levalbuterol |
Administration Route(s): | RESPIRATORY (INHALATION) |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-4145 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090297 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130426 |
Package NDC: | 0093-4145-64 |
Package Description: | 6 POUCH in 1 CARTON (0093-4145-64) > 4 VIAL, SINGLE-DOSE in 1 POUCH (0093-4145-04) > 3 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0093-4145-64 |
Proprietary Name | Levalbuterol |
Package Description | 6 POUCH in 1 CARTON (0093-4145-64) > 4 VIAL, SINGLE-DOSE in 1 POUCH (0093-4145-04) > 3 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0093-4145 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levalbuterol |
Dosage Form Name | SOLUTION |
Route Name | RESPIRATORY (INHALATION) |
Start Marketing Date | 20130426 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | LEVALBUTEROL HYDROCHLORIDE |
Strength Number | .31 |
Strength Unit | mg/3mL |
Pharmaceutical Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |